Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Lamperd Less Lethal stock

LLLI
US5136651099

Price

0.01
Today +/-
+0.00
Today %
+9.19 %
P

Lamperd Less Lethal stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Lamperd Less Lethal stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Lamperd Less Lethal stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Lamperd Less Lethal stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Lamperd Less Lethal's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Lamperd Less Lethal Stock Price History

DateLamperd Less Lethal Price
9/26/20240.01 undefined
9/25/20240.01 undefined
9/23/20240.01 undefined
9/20/20240.01 undefined
9/19/20240.01 undefined
9/18/20240.00 undefined
9/17/20240.01 undefined
9/16/20240.01 undefined
9/13/20240.01 undefined
9/12/20240.01 undefined
9/11/20240.01 undefined
9/9/20240.01 undefined
9/6/20240.00 undefined
9/5/20240.01 undefined
9/4/20240.01 undefined
9/3/20240.01 undefined

Lamperd Less Lethal Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lamperd Less Lethal, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lamperd Less Lethal from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lamperd Less Lethal’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lamperd Less Lethal. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lamperd Less Lethal’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lamperd Less Lethal’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lamperd Less Lethal’s growth potential.

Lamperd Less Lethal Revenue, EBIT and net profit per share

DateLamperd Less Lethal RevenueLamperd Less Lethal EBITLamperd Less Lethal Net Income
2012109,380 undefined-53,210 undefined-53,320 undefined
201180,800 undefined-155,460 undefined-157,280 undefined
2010229,200 undefined-75,060 undefined-76,590 undefined

Lamperd Less Lethal Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201020112012
000
---
---
000
000
---
000
---
59.4560.0864.85
---
Details

Keystats

ⓘ

Revenue and Growth

The Lamperd Less Lethal Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Lamperd Less Lethal is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (k)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (k)TOTAL ASSETS (k)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (k)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (k)TOTAL CAPITAL (k)
201020112012
     
000
19.3932.8650.01
000
153.9153.9153.9
000
173.29187.01203.91
159.43160.36163.05
000
000
000
000
17.8217.8217.82
177.25178.18180.87
350.54365.19384.78
     
59.4562.567.22
3.673.873.97
-3.89-4.04-4.1
000
000
-0.16-0.11-0.06
386.57359.44329.05
118.89118.69114.82
000
000
000
505.46478.13443.87
4.9810
000
000
4.9810
510.44479.13443.87
350.56365.2384.8
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Lamperd Less Lethal provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Lamperd Less Lethal's financial health and stability.

Assets

Lamperd Less Lethal's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Lamperd Less Lethal must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Lamperd Less Lethal after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Lamperd Less Lethal's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201020112012
000
000
000
000
000
000
000
000
000
000
000
000
000
000
000
---
000
000
-0.11-0.19-0.11
000

Lamperd Less Lethal stock margins

The Lamperd Less Lethal margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lamperd Less Lethal. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lamperd Less Lethal.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lamperd Less Lethal's sales revenue. A higher gross margin percentage indicates that the Lamperd Less Lethal retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lamperd Less Lethal's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lamperd Less Lethal's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lamperd Less Lethal's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lamperd Less Lethal. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lamperd Less Lethal's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lamperd Less Lethal Margin History

Lamperd Less Lethal Gross marginLamperd Less Lethal Profit marginLamperd Less Lethal EBIT marginLamperd Less Lethal Profit margin
201280.54 %-48.65 %-48.75 %
201170.19 %-192.4 %-194.65 %
201078.06 %-32.75 %-33.42 %

Lamperd Less Lethal Stock Sales Revenue, EBIT, Earnings per Share

The Lamperd Less Lethal earnings per share therefore indicates how much revenue Lamperd Less Lethal has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lamperd Less Lethal earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lamperd Less Lethal's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lamperd Less Lethal’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lamperd Less Lethal's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lamperd Less Lethal Revenue, EBIT and net profit per share

DateLamperd Less Lethal Sales per ShareLamperd Less Lethal EBIT per shareLamperd Less Lethal Earnings per Share
20120 undefined-0 undefined-0 undefined
20110 undefined-0 undefined-0 undefined
20100 undefined-0 undefined-0 undefined

Lamperd Less Lethal business model

Lamperd Less Lethal is one of the most popular companies on Eulerpool.com.

Lamperd Less Lethal Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Lamperd Less Lethal historical P/E ratio, EBIT multiple, and P/S ratio

Lamperd Less Lethal shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lamperd Less Lethal earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lamperd Less Lethal's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lamperd Less Lethal’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lamperd Less Lethal's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lamperd Less Lethal stock splits

In Lamperd Less Lethal's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Lamperd Less Lethal.

Lamperd Less Lethal Executives and Management Board

Barry Lamperd65
Lamperd Less Lethal President, Chief Executive Officer, Director (since 2005)
Compensation 125,000
Sharon Scott59
Lamperd Less Lethal Plant/Operation Manager
Compensation 110,000
Dominic Dicarlo64
Lamperd Less Lethal Vice President, Director (since 2005)
Compensation 16,000
D'arcy Bell59
Lamperd Less Lethal Vice President, Director (since 2005)
Edward Ferguson65
Lamperd Less Lethal Director
1
2

Most common questions regarding Lamperd Less Lethal

What is the P/E ratio of Lamperd Less Lethal 2024?

The P/E ratio cannot be calculated for Lamperd Less Lethal at the moment.

What is the P/S ratio of Lamperd Less Lethal 2024?

The P/S cannot be calculated for Lamperd Less Lethal currently.

What is the AlleAktien quality score of Lamperd Less Lethal?

The AlleAktien quality score for Lamperd Less Lethal is 3/10.

What is the revenue of Lamperd Less Lethal 2024?

The revenue cannot currently be calculated for Lamperd Less Lethal.

How high is the profit of Lamperd Less Lethal 2024?

The profit cannot currently be calculated for Lamperd Less Lethal.

What is the business model of Lamperd Less Lethal

No history available for Lamperd Less Lethal.

What is the Lamperd Less Lethal dividend?

Lamperd Less Lethal pays a dividend of 0 CAD distributed over payouts per year.

How often does Lamperd Less Lethal pay dividends?

The dividend cannot currently be calculated for Lamperd Less Lethal or the company does not pay out a dividend.

What is the Lamperd Less Lethal ISIN?

The ISIN of Lamperd Less Lethal is US5136651099.

What is the Lamperd Less Lethal ticker?

The ticker of Lamperd Less Lethal is LLLI.

How much dividend does Lamperd Less Lethal pay?

Over the past 12 months, Lamperd Less Lethal paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lamperd Less Lethal is expected to pay a dividend of 0 CAD.

What is the dividend yield of Lamperd Less Lethal?

The current dividend yield of Lamperd Less Lethal is .

When does Lamperd Less Lethal pay dividends?

Lamperd Less Lethal pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lamperd Less Lethal?

Lamperd Less Lethal paid dividends every year for the past 0 years.

What is the dividend of Lamperd Less Lethal?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lamperd Less Lethal located?

Lamperd Less Lethal is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Lamperd Less Lethal kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lamperd Less Lethal from 10/1/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Lamperd Less Lethal pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Lamperd Less Lethal in the year 2023?

In the year 2023, Lamperd Less Lethal distributed 0 CAD as dividends.

In which currency does Lamperd Less Lethal pay out the dividend?

The dividends of Lamperd Less Lethal are distributed in CAD.

All fundamentals about Lamperd Less Lethal

Our stock analysis for Lamperd Less Lethal Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lamperd Less Lethal Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.